Denali Therapeutics Inc
DNLI
NASDAQ
Biotechnology
$24.40
USD
-0.42 (-1.69%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.05B
Volume 876.2K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
PBLS | Parabilis Medicines Inc | - | - | - | - | |
TNGX | Tango Therapeutics Inc | $4.51B | - | +39.0% | - | |
RLAY | Relay Therapeutics Inc | $4.37B | - | +23.9% | - | |
CELC | Celcuity Inc | $4.36B | - | - | - | |
DNLI | Denali Therapeutics Inc | $4.05B | - | - | - | |
LEGN | Legend Biotech Corp | $4.00B | - | +56.4% | - | |
VKTX | Viking Therapeutics Inc | $3.93B | - | - | - | |
IDYA | IDEAYA Biosciences Inc | $3.55B | - | +3118.1% | - | |
VCYT | Veracyte Inc | $3.51B | 30.66 | +17.3% | - |
Top Peer by Growth
IDEAYA Biosciences Inc
+3118.1% YoY Revenue
Lowest P/E Ratio
Veracyte Inc
29.24x P/E
Best 1-Year Return
Relay Therapeutics Inc
+499.1% Return